Increase of hippocampal glutamate after electroconvulsive treatment: A quantitative proton MR spectroscopy study at 9.4 T in an animal model of depression

References

• Alcaro A, Panksepp J, Witczak J, Hayes DJ, Northoff G. 2010. Is subcortical-cortical midlineactivity in depression mediated by glutamate and GABA? A cross-species translational approach. Neurosci Biobehav Rev 34:592–605.
   PubMed Web of Science ®Google Scholar
• Attwell D, Laughlin SB. 2001. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133–1145.
   PubMed Web of Science ®Google Scholar
• Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. 2000. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47:305–313.
   PubMed Web of Science ®Google Scholar
• Belluzzi O, Puopolo M, Benedusi M, Kratskin I. 2004. Selective neuroinhibitory effects of taurine in slices of rat main olfactory bulb. Neuroscience 124:929–944.
   Google Scholar
• Block W, Traber F, von Widdern O, Metten M, Schild H, Maier W, . 2009. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int J Neuropsychopharmacol 12:415–422.
   Google Scholar
• Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Payne M, Moore D. 1994. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 18:1121–1127.
   PubMed Web of Science ®Google Scholar
• Chen W, Novotny EJ, Zhu XH, Rothman DL, Shulman RG. 1993. Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc Natl Acad Sci USA 90:9896–9900.
   Google Scholar
• Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C, . 2008. AMPA receptor subunit 1 (GluR-A) knockout mice show behavioural and biochemical features of depression. FASEB J 22:3129–3134.
   Google Scholar
• de Graaf RA, Mason GF, Patel AB, Behar KL, Rothman DL. 2003. In vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism. NMR Biomed 16:339–357.
   PubMed Web of Science ®Google Scholar
• de Graaf RA, Brown PB, McIntyre S, Nixon TW, Behar KL, Rothman DL. 2006. High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo. Magn Reson Med 56:386–394.
   Web of Science ®Google Scholar
• Drevets WC, Price JL, Furey ML. 2008. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213: 93–118.
   PubMed Web of Science ®Google Scholar
• Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. 2000. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 57:937–943.
   PubMed Web of Science ®Google Scholar
• Enkel T, Spanagel R, Vollmayr B, Schneider M. 2010. Stress triggers anhedonia in rats bred for learned helplessness. Behav Brain Res 209:183–186.
   Google Scholar
• Frahm J, Kruger G, Merboldt KD, Kleinschmidt A. 1996. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation in man. Magn Reson Med 35:143–148.
   Google Scholar
• Gray JA, Green AR. 1987. Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks. Br J Pharmacol 92:357–362.
   Google Scholar
• Gruetter R. 1993. Automatic. localized in vivo adjustment of all first- and second-order shim coils. Magn Reson Med 29: 804–811.
   PubMed Web of Science ®Google Scholar
• Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, . 2005. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry 58: 969–973.
   Google Scholar
• Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. 2007. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64:193–200.
   PubMed Web of Science ®Google Scholar
• Henn FA, Vollmayr B, Sartorius A. 2004. Mechanisms of depression: the role of neurogenesis. Drug Discovery Today: Dis Mech 4:407–411.
   Google Scholar
• Hennig J, Thiel T, Speck O. 1997. Improved sensitivity to over lapping multiplet signals in in vivo proton spectroscopy using a multiecho volume selective (CPRESS) experiment. Magn Reson Med 37:816–820.
   Google Scholar
• Kang I, Miller LG, Moises J, Bazan NG. 1991. GABAA receptor mRNAs are increased after electroconvulsive shock. Psychopharmacol Bull 27:359–363.
   Google Scholar
• Kendell SF, Krystal JH, Sanacora G. 2005. GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets 9:153–168.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Evans KR, Kruger S, Mayberg HS, Meyer JH, McCann S, . 2001. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 158:899–905.
   PubMed Web of Science ®Google Scholar
• Kram ML, Kramer GL, Steciuk M, Ronan PJ, Petty F. 2000. Effects of learned helplessness on brain GABA receptors. Neurosci Res 38:193–198.
   Google Scholar
• Kuczewski N, Langlois A, Fiorentino H, Bonnet S, Marissal T, Diabira D, . 2008. Spontaneous glutamatergic activity induces a BDNF-dependent potentiation of GABAergic synapses in the newborn rat hippocampus. J Physiol 586:5119–5128.
   Google Scholar
• Kugaya A, Sanacora G. 2005. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10:808–819.
   PubMed Web of Science ®Google Scholar
• Lloyd KG, Thuret F, Pilc A. 1985. Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. J Pharmacol Exp Ther 235:191–199.
   PubMed Web of Science ®Google Scholar
• Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. 2000. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47:1043–1049.
   PubMed Web of Science ®Google Scholar
• Mangia S, Giove F, Tkac I, Logothetis NK, Henry PG, Olman CA, . 2009. Metabolic and hemodynamic events after changes in neuronal activity: current hypotheses, theoretical predictions and in vivo NMR experimental findings. J Cereb Blood Flow Metab 29:441–463.
   Google Scholar
• Martin P, Pichat P, Massol J, Soubrie P, Lloyd KG, Puech AJ. 1989. Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants. Neuropsychobiology 22:220–224.
   Google Scholar
• Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny EJ. 1995. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 15:12–25.
   PubMed Web of Science ®Google Scholar
• Mathews GC, Diamond JS. 2003. Neuronal glutamate uptake Contributes to GABA synthesis and inhibitory synaptic strength. J Neurosci 23:2040–2048.
   Google Scholar
• Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, . 2000. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48:830–843.
   PubMed Web of Science ®Google Scholar
• Merboldt KD, Bruhn H, Hanicke W, Michaelis T, Frahm J. 1992. Decrease of glucose in the human visual cortex during photic stimulation. Magn Reson Med 25:187–194.
   PubMed Web of Science ®Google Scholar
• Merkl A, Schubert F, Quante A, Luborzewski A, Brakemeier EL, Grimm S, . 2011 Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biol Psychiatry 69:772–779.
   PubMed Web of Science ®Google Scholar
• Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. 2003. Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology 28:720–725.
   PubMed Web of Science ®Google Scholar
• Milne A, MacQueen GM, Yucel K, Soreni N, Hall GB. 2009. Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study. Neuroimage 47:36–41.
   PubMed Web of Science ®Google Scholar
• Mineur YS, Picciotto MR, Sanacora G, 2007. Antidepressant-like effects of ceftriaxone in male C57BL/6J mice. Biol Psychiatry 61:250–252.
   PubMed Web of Science ®Google Scholar
• Nandhini AT, Thirunavukkarasu V, Anuradha CV. 2005. Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 31:337–344.
   PubMed Web of Science ®Google Scholar
• Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539–7547.
   PubMed Web of Science ®Google Scholar
• Oja SS, Saransaari P. 2000. Modulation of taurine release by glutamate receptors and nitric oxide. Prog Neurobiol 62:407–425.
   Google Scholar
• Overmier JB, Seligman ME. 1967. Effects of inescapable shock upon subsequent escape and avoidance responding. J Comp Physiol Psychol 63:28–33.
   PubMed Web of Science ®Google Scholar
• Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M, Carpio C, . 2007. Antidepressant-induced neurogenesis in the hippocampus of adult nonhuman primates. J Neurosci 27: 4894–4901.
   PubMed Web of Science ®Google Scholar
• Petty F, Sherman AD. 1981. GABAergic modulation of learned helplessness. Pharmacol Biochem Behav 15:567–570.
   Google Scholar
• Petty F, McChesney C, Kramer G. 1985. Intracortical glutamate injection produces helpless-like behaviour in the rat. Pharmacol Biochem Behav 22:531–533.
   PubMed Web of Science ®Google Scholar
• Pfeuffer J, Tkac I, Provencher SW, Gruetter R. 1999. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson 141:104–120.
   PubMed Web of Science ®Google Scholar
• Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, . 2003. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 122:185–192.
   PubMed Web of Science ®Google Scholar
• Provencher SW. 1993. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672–679.
   PubMed Web of Science ®Google Scholar
• Sanacora G, Saricicek A. 2007. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 6:127–140.
   PubMedGoogle Scholar
• Sanacora G, Mason GF, Rothman DL, Krystal JH. 2002. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159:663–665.
   PubMed Web of Science ®Google Scholar
• Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, . 2003. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160:577–579.
   PubMed Web of Science ®Google Scholar
• Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, . 2004. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705–713.
   PubMed Web of Science ®Google Scholar
• Saransaari P, Oja SS. 2000. Taurine and neural cell damage. Amino Acids 19:509–526.
   PubMed Web of Science ®Google Scholar
• Sartorius A, Vollmayr B, Neumann-Haefelin C, Ende G, Hoehn M, Henn FA. 2003. Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment. Neuroreport 14:2199–2201.
   PubMed Web of Science ®Google Scholar
• Sartorius A, Mahlstedt MM, Vollmayr B, Henn FA, Ende G. 2007. Elevated spectroscopic glutamate/gamma-amino butyric acid in rats bred for learned helplessness. Neuroreport 18: 1469–1473.
   PubMedGoogle Scholar
• Sherman AD, Petty F. 1980. Neurochemical basis of the action of antidepressants on learned helplessness. Behav Neural Biol 30:119–134.
   PubMedGoogle Scholar
• Shumake J, Edwards E, Gonzalez-Lima F. 2002. Dissociation of septo-hippocampal metabolism in the congenitally helpless rat. Neuroscience 114:373–377.
   Google Scholar
• Sivakumaran S, Mohajerani MH, Cherubini E. 2009. At immature mossy-fiber-CA3 synapses, correlated presynaptic and postsynaptic activity persistently enhances GABA release and network excitability via BDNF and cAMP-dependent PKA. J Neurosci 29:2637–2647.
   Google Scholar
• Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, . 2004. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208–219.
   PubMedGoogle Scholar
• van der Hart MG, Czeh B, de Biurrun G, Michaelis T, Watanabe T, Natt O, Frahm J, Fuchs E. 2002. Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume. Mol Psychiatry 7:933–41.
   PubMed Web of Science ®Google Scholar
• Videbech P, Ravnkilde B, Pedersen AR, Egander A, Landbo B, Rasmussen NA, . 2001. The Danish PET/depression project: PET findings in patients with major depression. Psychol Med 31:1147–1158.
   PubMed Web of Science ®Google Scholar
• Videbech P, Ravnkilde B, Pedersen TH, Hartvig H, Egander A, Clemmensen K, . 2002. The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand 106:35–44.
   PubMedGoogle Scholar
• Vollmayr B, Henn FA. 2001. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc 8:1–7.
   PubMedGoogle Scholar
• Yildiz-Yesiloglu A, Ankerst DP. 2006. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res 147:1–25.
   PubMed Web of Science ®Google Scholar
• Zarate CA, Manji HK. 2008. Riluzole in psychiatry: a systematic review of the literature. Expert Opin Drug Metab Toxicol 4:1223–1234.
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Payne JL, Quiroz J, Sporn J, Denicoff KK, Luckenbaugh D, . 2004. An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 161:171–174.
   PubMed Web of Science ®Google Scholar
• Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA, Thome J. 2007. Reduced expression of complexins I and II in rats bred for learned helplessness. Brain Res 1144:202–208.
   Google Scholar
• Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA. 2009. Reduced expression of GABA transporter GAT3 in helpless rats. An animal model of depression. Neurochem Res.
   Google Scholar
• Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA. 2010. Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology 58:465–73.
   PubMed Web of Science ®Google Scholar